The term “seronegative MG” is unfavorable because of its ambiguity since, with the improvement of detection techniques, both MuSK and LRP4 antibodies have been identified from patients once defined as seronegative MG by studying new targets (Fichtner et al., 2020). The gene discussed is LRP4; the disease is myasthenia gravis.